ES8607734A1 - Procedimiento para producir un preparado farmaceutico desti-nado a aplicacion por via topica - Google Patents

Procedimiento para producir un preparado farmaceutico desti-nado a aplicacion por via topica

Info

Publication number
ES8607734A1
ES8607734A1 ES542846A ES542846A ES8607734A1 ES 8607734 A1 ES8607734 A1 ES 8607734A1 ES 542846 A ES542846 A ES 542846A ES 542846 A ES542846 A ES 542846A ES 8607734 A1 ES8607734 A1 ES 8607734A1
Authority
ES
Spain
Prior art keywords
concentration
ions
carrier
calcium
active substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES542846A
Other languages
English (en)
Other versions
ES542846A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Goedecke GmbH
Original Assignee
Goedecke GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3416777A external-priority patent/DE3416777C2/de
Application filed by Goedecke GmbH filed Critical Goedecke GmbH
Publication of ES8607734A1 publication Critical patent/ES8607734A1/es
Publication of ES542846A0 publication Critical patent/ES542846A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROCEDIMIENTO PARA PRODUCIR UN PREPARADO FARMACEUTICO. COMPRENDE: A) DISTRIBUIR EN UN VEHICULO FARMACEUTICO ACUOSO UNA SUSTANCIA ACTIVA, PARA FORMAR UNA MEZCLA B) DISPERSAR Y EMULSIONAR A LA MEZCLA DE (A); Y C) CONFORMAR Y ENVASAR A LA MEZCLA DE (B). EL VEHICULO ES AGUA Y LA SUSTANCIA ACTIVA ELEVA LA PERMEABILIDAD DEL CALCIO DE LA MEMBRANA PLASMATICA Y SE ELIGE ENTRE: UNA COMBINACION QUE CONTIENE DE 0,2 A 10% EN PESO DE UNA MEZCLA IONIZABLE FARMACOLOGICAMENTE TOLERABLE DE SALES DE CALCIO (CA2B) Y DE POTASIO (KB) EN RELACION MOLAR CA2B/KB ENTRE 1:3 Y 4:1; UN IONOFORO DE CA2B QUE SE COMBINA CON SALES DE CALCIO SEGUN CONCENTRACIONES ENTRE 0,1 A 50 MM Y TIENE CONCENTRACIONES ENTRE 3.108 Y 3.10C6M Y UN AGONISTA DE CA2B QUE TIENE UNA CONCENTRACION ENTRE 10C5 Y 10C9M, EN PRESENCIA DE UNA CONCENTRACION DE KB ENTRE 5.10C3 Y 2.10C2M Y DE UNA CONCENTRACION DE IONES CA2B ENTRE 10C3 Y 3.10C2M Y LAS SALES CALCICAS SE ELIGEN ENTRE SULFATOS, CLOROSOS, MALEATOS Y CITRATOS. SE EMPLEA PARA ESTIMULAR LA GRANULACION Y EPITELIZACION DE LAS HERIDAS.
ES542846A 1984-05-07 1985-05-06 Procedimiento para producir un preparado farmaceutico desti-nado a aplicacion por via topica Expired ES8607734A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3416777A DE3416777C2 (de) 1984-05-07 1984-05-07 Pharmazeutische topische Zubereitungen
DE19843435113 DE3435113A1 (de) 1984-05-07 1984-09-25 Pharmazeutische topische zubereitungen zur foerderung der wundgranulation und epithelisation

Publications (2)

Publication Number Publication Date
ES8607734A1 true ES8607734A1 (es) 1986-06-01
ES542846A0 ES542846A0 (es) 1986-06-01

Family

ID=25820959

Family Applications (1)

Application Number Title Priority Date Filing Date
ES542846A Expired ES8607734A1 (es) 1984-05-07 1985-05-06 Procedimiento para producir un preparado farmaceutico desti-nado a aplicacion por via topica

Country Status (16)

Country Link
EP (1) EP0165430B1 (es)
AU (1) AU570558B2 (es)
CA (1) CA1258231A (es)
CS (1) CS257788B2 (es)
DD (1) DD232819A5 (es)
DE (2) DE3435113A1 (es)
DK (1) DK201785A (es)
ES (1) ES8607734A1 (es)
FI (1) FI81260C (es)
GR (1) GR851098B (es)
HU (1) HU196902B (es)
IL (1) IL74897A (es)
NO (1) NO851793L (es)
NZ (1) NZ211994A (es)
PH (1) PH21464A (es)
YU (1) YU44497B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3614095A1 (de) * 1986-04-25 1987-10-29 Goedecke Ag Oxyalkylcellulose enthaltende gelzubereitung
FR2725901B1 (fr) * 1994-10-25 1997-06-27 Thorel Jean Noel Utilisation du calcium en cosmetologie dans le traitement local des phenomenes irritatifs
FR2726187A1 (fr) * 1994-10-26 1996-05-03 Jean Noel Thorel Utilisation du calcium par voie topique dans le traitement local des dermatoses hyperproliferatives comme le psoriasis
DE4439662C2 (de) * 1994-11-07 1997-10-02 Max Planck Gesellschaft Verfahren zur Aktivitätsbestimmung von Phosphotyrosinphosphatasen und zur Identifizierung von Effektoren davon
DE4447586C2 (de) * 1994-11-07 1998-12-24 Max Planck Gesellschaft Verwendung von Ionophoren als Effektoren von PTPasen
WO1996019228A1 (en) * 1994-12-21 1996-06-27 Cosmederm Technologies Formulations and methods for reducing skin irritation
US7404967B2 (en) 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
WO2000009176A1 (en) * 1998-08-11 2000-02-24 Susanna Elizabeth Chalmers A wound treatment composition and a wound dressing containing it
DE102007002073A1 (de) 2007-01-09 2008-07-10 Matthias Habenicht Mittel zur Pflege und antimikrobiellen Behandlung der Haut

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2725261C2 (de) * 1977-06-03 1986-10-09 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Transparentes Flüssigkeitsverbandmaterial, seine Herstellung und Verwendung

Also Published As

Publication number Publication date
DK201785D0 (da) 1985-05-06
CS257788B2 (en) 1988-06-15
NZ211994A (en) 1988-04-29
EP0165430B1 (de) 1989-04-05
EP0165430A1 (de) 1985-12-27
FI851754A0 (fi) 1985-05-03
CA1258231A (en) 1989-08-08
AU570558B2 (en) 1988-03-17
CS323585A2 (en) 1987-09-17
AU4204185A (en) 1985-11-14
PH21464A (en) 1987-10-28
YU74685A (en) 1988-10-31
HUT38247A (en) 1986-05-28
DD232819A5 (de) 1986-02-12
ES542846A0 (es) 1986-06-01
GR851098B (es) 1985-11-25
FI81260B (fi) 1990-06-29
YU44497B (en) 1990-08-31
HU196902B (en) 1989-02-28
NO851793L (no) 1985-11-08
FI81260C (fi) 1990-10-10
IL74897A0 (en) 1985-07-31
DK201785A (da) 1985-11-08
IL74897A (en) 1989-09-10
DE3435113A1 (de) 1986-04-03
DE3569197D1 (en) 1989-05-11
FI851754L (fi) 1985-11-08

Similar Documents

Publication Publication Date Title
EP0206291A3 (en) Sprayable pharmaceutical preparation for topical application
MY102422A (en) Intranasally applicable powdery pharmaceutical composition.
NZ216632A (en) Multi-component, aqueous polymer compositions containing c 16 + aliphatic surface active compound as evaporation retarding agent
ES8607734A1 (es) Procedimiento para producir un preparado farmaceutico desti-nado a aplicacion por via topica
DE3671700D1 (de) Blutstillende irrigationsloesung.
EP0156924A4 (en) CHEMICALLY ACTIVE COMPOSITION CONTAINING FERROUS IONS.
MY101750A (en) Improvements in or relating to calcium salts.
ATE95070T1 (de) Pharmazeutische zusammensetzung mit gehalt an einer mischung von kollagen und einem antiseptischen und/oder entzuendungshemmenden wirkstoff und verfahren zu ihrer herstellung.
IL78061A0 (en) Pharmaceutical compositions based on guar gum and other antacids for protection of the oesogastroduodenal mucous membrane
DE3462852D1 (en) Medicament preparation for external use comprising adenosin for the treatment of herpes
ZA853432B (en) Topical pharmaceutical preparations,process for the manufacture thereof,and their application to promote granulation and epithelization of wounds
ATE33620T1 (de) Wasserloesliche zusammensetzungen zur herstellung analytischer loesungen.
LV11818A (lv) Jauna farmaceitiska kompozicija stabilas pulverveida zalu formas pagatavosanai
JPS5578083A (en) Stabilization of soil
GB954268A (en) Decongestant compositions comprising n-acylated sulphydryl compounds
ES2103826T3 (es) Preparacion de material conteniendo silicio nitrurable y material resultante.
ATE24716T1 (de) Lenkotrien-antagonisten.
ES2001061A6 (es) Un procedimiento para la preparacion de una forma de dosificacion rectal medicamentosa.
JPS5411292A (en) Immobilized material having enzymatic activity and its preparation
BG96407A (en) Medicaments for local treatment of wounds and inflammatory foci
ES2033927T3 (es) Utilizacion de la forma farmaceutica de "gel" conteniendo acido n-(2,6-cicloro-m-tolil)-antranilico (acido meclofenamico) utilizable en terapia de uso topico.
ES8506614A1 (es) Derivados del acido d-2-(6-metoxi-2-naftil)-propionico
AR247420A1 (es) Composicion y procedimiento para corregir la productividad y/o capacidad de inyeccion de pozos de petroleo.
EP0189101A3 (en) Compounds having mucolytic and bronchodilating activity, a process for their preparation and pharmaceutical composition containing them as active principle
MY106605A (en) Compositions for the treatment of leishmaniasis